Inventor · disambiguated record
Samuele Lillini
Also filed as: LILLINI SAMUELE
6 granted patents·3 pending applications·15 citations·filing 2008–2025
73Inventor score
Top patents by PatentIndex Score
9 records- 0184US12285396B2Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereofDOMPE FARM SPA·Filed 2019·Granted Apr 29, 2025·2 cites·14 claims
- 0283US8268827B2Pyridazinone derivatives as PARP inhibitorsBRANCA DANILA·Filed 2008·Granted Sep 18, 2012·13 cites·12 claims
- 0364US12365644B2Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2021·Granted Jul 22, 2025·0 cites·18 claims
- 0460US2025312301A1Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereofDOMPE FARM SPA·Filed 2025·Application pending·0 cites
- 0556US2025025435A1Co-crystals of nonsteroidal anti-inflammatory drugs, lysine and gabapentin, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 0650US2023165820A1Synergistic admixtures of gabapentin and ketoprofen, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 0749US11046662B22-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthmaDOMPE FARM SPA·Filed 2018·Granted Jun 29, 2021·0 cites·3 claims
- 0844US10196368B22-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthmaDOMPE FARM SPA·Filed 2015·Granted Feb 5, 2019·0 cites·18 claims
- 0937US10246448B24-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as TRPM8 antagonistsDOMPE FARM SPA·Filed 2016·Granted Apr 2, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Samuele Lillini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →